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Mini Review
The high mortality verified worldwide in patients with sepsis in intensive care units (ICU) is a sad social problem that needs to be solved. Sepsis is still a fatal condition besides the reporter of many biomarkers of diagnostic and prognostic. “In 
the United States was estimated the occurrence of 751,000 cases of severe sepsis per year (3.0 cases per 1,000 population 
and 2.26 cases per 100 hospital discharges), of whom 383,000 
(51.1%) received intensive care and an additional 130,000 
(17.3%) were ventilated in an intermediate care unit or cared 
for in a coronary care unit. Mortality was 28.6% or 215,000 
deaths nationally. The average costs per case were $22,100, 
with annual total costs of $16.7 billion nationally. The Incidence 
was projected to increase by 1.5%per annum [1] from the onset 
of sepsis syndrome, an imbalance between pro-inflammatory 
and anti-inflammatory mechanisms occurs. The intensity and 
duration of the inflammatory response has been closely related 
with mortality, since once out of control inflammation leads to 
massive production of pro-inflammatory cytokines, which in 
turn leads to coagulation disorder, tissue injury, multiple organ dysfunction, and ultimately to death. All studies conducted 
until now highlight difficulties and inability to address the heterogeneity that characterizes sepsis.
Simultaneously inflammatory response is triggered 
as well others molecular mechanism involving hormonal metabolic control, macro and microcirculation controls 
are call to react changing their homeostasis [2]. At 
 
microcirculation blood flow through small vessels favor gas 
exchanges such as oxygen and nitric oxide (NO) with carbon 
dioxide, deliver nutrients and remove metabolites and waste 
products [3]. Erythrocytes deliver O2 and NO in lower oxygen 
partial pressure (Pa O2) and scavenge them at high PaO2 [3]. The ability of erythrocyte to deliver or retain NO depends on the membrane AChE enzyme activity and protein conformations 
[4]. Microcirculation hemodynamic influences blood pressure, 
hemorheology and micro vascular cells wall participate in 
inflammation. When microcirculation starts to be compromised severe uncontrolled outcomes appear. Impaired sensitivity of endothelial cell (EC) in microvasculature to vasoconstriction/vasodilating substance is a signal of endothelium dysfunction 
[5]. This is worsening by the decrease in blood flow rate consequently to decreased erythrocyte deformability and 
increase erythrocyte aggregation [5]. So, there are created 
conditions for a thigh permanence of white blood cells (WBC) in 
the EC surface [5]. Under inflammatory stimuli the WBC decrease its rolling velocity, increasing adherence and transmigration until 
the focus of tissue injury [6]. Neutrophils recruitment to sites of infection is a critical element of the innate immune response, 
being the cells that migrate first to an infectious site responding to chemo attractants factors and cytokines. Neutrophils are able to kill microorganisms by releasing bactericidal agents like oxygen and nitrogen reactive species. The neutrophils, in 
addition also release, cytokines and chemokines which enhance 
the recruitment and activation of immune cells. During the pro-
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inflammatory phase, cytokines released from innate immune system cells contribute to endothelial dysfunction by different 
ways, including the interference with the expression of iNOS that 
originates nitric oxide (NO) increase. The current knowledge 
on the mechanism by which NO modulates vascular function/dysfunction in sepsis is limited. 
In sepsis, the initiating stimuli of systemic inflammation 
are often bacterial components which induce the secretion of 
pro-inflammatory cytokines from cells of the immune system 
[2]. The release of those pro-inflammatory mediators in the central nervous system at the onset of sepsis leads to neuronal 
loss [7]. This finding is on the base of cognitive impairment 
with electroencephalographic changes observed in some sepsis 
survivors [7].Sepsis presents an acute pattern of response of the immune 
system to the injury with a myriad of changes in mediators of 
inflammation, hemostasis and metabolism [8]. Insulin resistance 
in sepsis is largely attributed to the higher levels of TNF-
alpha, IL-1, and IL-6 [8]. Insulin, glucose and lactate levels are 
associated with the clinical sepsis score APACHE-II values [9]. In response to endotoxin, the body exhibits transient systemic insulin resistance, in an attempt to spare glucose for utilization 
by immune cells [10]. Persistent insulin resistance appears in sepsis because of the nitrosylation or nitration of its receptor 
[10]. Insulin resistance can be eliminated in some patients with sepsis by continuous intravenous infusion of insulin in the form of 
glucose-insulin-potassium (GIP) regimen that improves survival 
[11]. This is presumably related with decreased expression of 
NF-kB, IL-1 and IL-6 [11]. However, the degree of cell dysfunction resulting from the hyperglycaemia (related to insulin resistance) generates a multitude of changes in metabolic, hemostasis, and 
microcirculatory blood flow in patients unable them to survive 
[12]. Hyperglycemia generates imbalanced oxidant and anti-
oxidant pathways, generating high levels of oxygen and reactive nitrogen species accompanied by abolished plasma antioxidant 
capacity [13]. This increased oxidative state contributes to the 
endothelial dysfunction with over expression of inducible nitric 
oxide syntheses (iNOS) and high release of NO to the lumen [14]. NO scavenged by erythrocyte impaired the deformability that 
clogs capillaries in the microcirculation [15]. Microcirculation issues gained increased importance in sepsis. The introduction of bedside techniques into clinical 
practice allow functional hemodynamic monitoring showing microcirculatory failure associate to adverse outcomes in 
patient’s sepsis at intensive care unit (ICU) [16]. The complexity 
of the systemic inflammatory response in different phases of sepsis, the lack of progress in treatment and also in patients’ 
diagnosis and stratification demonstrate the lack in knowledge of sepsis pathophysiology. The approach of measuring a simple 
inflammatory marker is not enough to assess patients’ status. To direct appropriate therapy to individual patient and to improve 
diagnosis and stratification of patients it is necessary to identify 
the inflammatory response profile of different patients using 
multiple markers, and to unveil the relation of those profiles with 
the disease severity. To achieve that an accompanying follow-up 
evaluation of inflammatory, hemostatics, biorheological and microcirculatory markers is needed. In this perspective, the probability of an individualized treatment based on clinical and 
laboratory evaluations will be higher.
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